Skip to main content
Erschienen in: Acta Neuropathologica 2/2011

01.02.2011 | Original Paper

The pathological process underlying Alzheimer’s disease in individuals under thirty

verfasst von: Heiko Braak, Kelly Del Tredici

Erschienen in: Acta Neuropathologica | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Brains of 42 individuals between the ages of 4 and 29 were examined with antibodies (AT8, 4G8) and silver stains for the presence of intraneuronal and extracellular protein aggregates associated with Alzheimer’s disease. Thirty-eight of 42 (38/42) cases displayed abnormally phosphorylated tau protein (pretangle material) in nerve cells or in portions of their cellular processes, and 41/42 individuals showed no extracellular amyloid-β protein deposition or neuritic plaques—an individual with Down syndrome was the only exception. In 16/42 cases abnormal tau was found in the transentorhinal region, and in 3/42 cases this site was Gallyas-positive for isolated NFTs (NFT stage I). Of 26 cases that lacked abnormal tau in the transentorhinal region, 4 did not show pretangle material at subcortical sites. The remaining 22 of these same 26 cases, however, had subcortical lesions confined to non-thalamic nuclei with diffuse projections to the cerebral cortex, and, remarkably, in 19/22 individuals the pretangle material was confined to the noradrenergic coeruleus/subcoeruleus complex. Assuming the pretangle alterations are not transient and do not regress, these findings may indicate that the Alzheimer’s disease-related pathological process leading to neurofibrillary tangle formation does not begin in the cerebral cortex but, rather, in select subcortical nuclei, and it may start quite early, i.e., before puberty or in early young adulthood.
Literatur
1.
Zurück zum Zitat Alafuzoff I, Arzberger T, Al-Sarraj S et al (2008) Staging of neurofibrillary pathology in Alzheimer’s disease: a study for the Brain Net Europe Consortium. Brain Pathol 18:484–496PubMed Alafuzoff I, Arzberger T, Al-Sarraj S et al (2008) Staging of neurofibrillary pathology in Alzheimer’s disease: a study for the Brain Net Europe Consortium. Brain Pathol 18:484–496PubMed
2.
Zurück zum Zitat Alonso AC, Li B, Grundke-Iqbal I, Iqbal K (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5:375–384CrossRefPubMed Alonso AC, Li B, Grundke-Iqbal I, Iqbal K (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5:375–384CrossRefPubMed
3.
Zurück zum Zitat Amieva H, Le Goff M, Millet X et al (2008) Prodromal Alzheimer’s disease: successive emergence of clinical symptoms. Ann Neurol 64:492–498CrossRefPubMed Amieva H, Le Goff M, Millet X et al (2008) Prodromal Alzheimer’s disease: successive emergence of clinical symptoms. Ann Neurol 64:492–498CrossRefPubMed
4.
Zurück zum Zitat Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1:103–116CrossRefPubMed Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1:103–116CrossRefPubMed
5.
Zurück zum Zitat Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus–norepinephrine function: adaptive gain and optimal performance. Ann Rev Neurosci 28:403–450CrossRefPubMed Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus–norepinephrine function: adaptive gain and optimal performance. Ann Rev Neurosci 28:403–450CrossRefPubMed
6.
Zurück zum Zitat Baker KG, Törk I, Hornung JP, Halasz P (1989) The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res 77:257–270CrossRefPubMed Baker KG, Törk I, Hornung JP, Halasz P (1989) The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res 77:257–270CrossRefPubMed
7.
Zurück zum Zitat Bancher C, Brunner C, Lassmann H et al (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99CrossRefPubMed Bancher C, Brunner C, Lassmann H et al (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99CrossRefPubMed
8.
Zurück zum Zitat Beach TG, White CL 3rd, Hladik CL et al (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174CrossRefPubMed Beach TG, White CL 3rd, Hladik CL et al (2009) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169–174CrossRefPubMed
9.
Zurück zum Zitat Beach TG, Adler CH, Sue SI et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702CrossRefPubMed Beach TG, Adler CH, Sue SI et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702CrossRefPubMed
10.
11.
Zurück zum Zitat Bobinski M, Wegiel J, Tarnawski M et al (1998) Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 799:156–158CrossRefPubMed Bobinski M, Wegiel J, Tarnawski M et al (1998) Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 799:156–158CrossRefPubMed
12.
Zurück zum Zitat Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567CrossRefPubMed Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567CrossRefPubMed
13.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
14.
Zurück zum Zitat Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216CrossRefPubMed Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216CrossRefPubMed
15.
Zurück zum Zitat Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357CrossRefPubMed Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351–357CrossRefPubMed
16.
Zurück zum Zitat Braak H, Del Tredici K (2004) Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation. Neurobiol Aging 25:713–718CrossRefPubMed Braak H, Del Tredici K (2004) Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation. Neurobiol Aging 25:713–718CrossRefPubMed
17.
Zurück zum Zitat Braak H, Braak E, Yilmazer D, Schultz C, Bohl J (1995) Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathologic diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 14–19 Braak H, Braak E, Yilmazer D, Schultz C, Bohl J (1995) Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML (eds) Neuropathologic diagnostic criteria for brain banking. IOS Press, Amsterdam, pp 14–19
18.
Zurück zum Zitat Braak H, Del Tredici K, Braak E (2003) Spectrum of pathology. In: Petersen R (ed) Mild cognitive impairment. Oxford University Press, New York, pp 149–189 Braak H, Del Tredici K, Braak E (2003) Spectrum of pathology. In: Petersen R (ed) Mild cognitive impairment. Oxford University Press, New York, pp 149–189
19.
Zurück zum Zitat Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–210CrossRefPubMed Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–210CrossRefPubMed
20.
Zurück zum Zitat Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404CrossRefPubMed Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404CrossRefPubMed
21.
Zurück zum Zitat Busch C, Bohl J, Ohm TG (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401–406CrossRefPubMed Busch C, Bohl J, Ohm TG (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401–406CrossRefPubMed
22.
Zurück zum Zitat Cowan CM, Bossing T, Page A, Shepherd D, Mudher A (2010) Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol 120:593–604CrossRefPubMed Cowan CM, Bossing T, Page A, Shepherd D, Mudher A (2010) Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol 120:593–604CrossRefPubMed
23.
Zurück zum Zitat Davies DC, Brooks JW, Lewis DA (1993) Axonal loss from the olfactory tracts in Alzheimer’s disease. Neurobiol Aging 14:353–357CrossRefPubMed Davies DC, Brooks JW, Lewis DA (1993) Axonal loss from the olfactory tracts in Alzheimer’s disease. Neurobiol Aging 14:353–357CrossRefPubMed
24.
Zurück zum Zitat Delacourte A, Défossez A (1986) Alzheimer’s disease: tau proteins, the promoting factors of microtubule assembly, are major antigenic components of paired helical filaments. J Neurol Sci 76:173–186CrossRefPubMed Delacourte A, Défossez A (1986) Alzheimer’s disease: tau proteins, the promoting factors of microtubule assembly, are major antigenic components of paired helical filaments. J Neurol Sci 76:173–186CrossRefPubMed
25.
Zurück zum Zitat Del Tredici K, Braak H (2008) Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign. Commentary on “No disease in the brain of a 115-year-old woman”. Neurobiol Aging 29:1133–1136CrossRefPubMed Del Tredici K, Braak H (2008) Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign. Commentary on “No disease in the brain of a 115-year-old woman”. Neurobiol Aging 29:1133–1136CrossRefPubMed
26.
Zurück zum Zitat Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson pathology begin in the brain? J Neuropathol Exp Neurol 61:413–425PubMed Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson pathology begin in the brain? J Neuropathol Exp Neurol 61:413–425PubMed
27.
Zurück zum Zitat Devanand DP, Tabert MH, Cuasay K et al (2010) Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 31:1593–1600CrossRefPubMed Devanand DP, Tabert MH, Cuasay K et al (2010) Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging 31:1593–1600CrossRefPubMed
28.
Zurück zum Zitat Dickson DW (1997) Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann Neurol 42:541–544CrossRefPubMed Dickson DW (1997) Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann Neurol 42:541–544CrossRefPubMed
29.
Zurück zum Zitat Dickson DW (1998) Aging in the central nervous system. In: Markesbery WR (ed) Neuropathology of dementing disorders. Arnold, London, pp 56–88 Dickson DW (1998) Aging in the central nervous system. In: Markesbery WR (ed) Neuropathology of dementing disorders. Arnold, London, pp 56–88
30.
Zurück zum Zitat Dickson DW, Crystal HA, Mattiace LA et al (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189CrossRef Dickson DW, Crystal HA, Mattiace LA et al (1991) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189CrossRef
31.
Zurück zum Zitat Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson’s disease. Mov Disord 25(Suppl. 1):S78–S82CrossRefPubMed Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson’s disease. Mov Disord 25(Suppl. 1):S78–S82CrossRefPubMed
32.
Zurück zum Zitat Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400CrossRefPubMed Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 23:394–400CrossRefPubMed
33.
Zurück zum Zitat Doty RL (2003) Odor perception in neurodegenerative disease. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd edn. Marcel Dekker, New York, pp 479–501 Doty RL (2003) Odor perception in neurodegenerative disease. In: Doty RL (ed) Handbook of olfaction and gustation, 2nd edn. Marcel Dekker, New York, pp 479–501
34.
Zurück zum Zitat Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18:362–369CrossRefPubMed Duyckaerts C, Hauw JJ (1997) Prevalence, incidence and duration of Braak’s stages in the general population: can we know? Neurobiol Aging 18:362–369CrossRefPubMed
35.
Zurück zum Zitat Frautschy SA, Cole GM (2010) Why pleiotropic interventions are needed for Alzheimer’s disease. Mol Neurobiol 41:392–409CrossRefPubMed Frautschy SA, Cole GM (2010) Why pleiotropic interventions are needed for Alzheimer’s disease. Mol Neurobiol 41:392–409CrossRefPubMed
36.
Zurück zum Zitat German DC, White CL, Sparkman DR (1987) Alzheimer’s disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21:305–312CrossRefPubMed German DC, White CL, Sparkman DR (1987) Alzheimer’s disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience 21:305–312CrossRefPubMed
37.
Zurück zum Zitat German DC, Walker BS, Manaye K, Smith WK, Woodward DJ, North AJ (1988) The human locus coeruleus: computer reconstruction of cellular distribution. J Neurosci 8:193–203 German DC, Walker BS, Manaye K, Smith WK, Woodward DJ, North AJ (1988) The human locus coeruleus: computer reconstruction of cellular distribution. J Neurosci 8:193–203
38.
Zurück zum Zitat German DC, Manaye KF, White CL 3rd (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676CrossRefPubMed German DC, Manaye KF, White CL 3rd (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676CrossRefPubMed
39.
40.
Zurück zum Zitat Goedert M, Jakes R, Crowther RA et al (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90:5066–5070CrossRefPubMed Goedert M, Jakes R, Crowther RA et al (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90:5066–5070CrossRefPubMed
41.
Zurück zum Zitat Goedert M, Trojanowski JQ, Lee VMY (1997) The neurofibrillary pathology of Alzheimer’s disease. In: Rosenberg RN (ed) The molecular and genetic basis of neurological disease, 2nd edn. Butterworth-Heinemann, Boston, pp 613–627 Goedert M, Trojanowski JQ, Lee VMY (1997) The neurofibrillary pathology of Alzheimer’s disease. In: Rosenberg RN (ed) The molecular and genetic basis of neurological disease, 2nd edn. Butterworth-Heinemann, Boston, pp 613–627
42.
Zurück zum Zitat Grinberg LT, Rüb U, Ferretti REL, Brazilian Brain Bank Study Group et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406–416CrossRefPubMed Grinberg LT, Rüb U, Ferretti REL, Brazilian Brain Bank Study Group et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406–416CrossRefPubMed
43.
Zurück zum Zitat Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917CrossRefPubMed Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913–4917CrossRefPubMed
44.
Zurück zum Zitat Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327–335CrossRefPubMed Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer’s disease. Neurobiol Aging 28:327–335CrossRefPubMed
45.
Zurück zum Zitat Haglund M, Sjöbeck M, Englund E (2006) Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: possible implications for diagnosis and treatment. Neuropathology 26:528–532CrossRefPubMed Haglund M, Sjöbeck M, Englund E (2006) Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: possible implications for diagnosis and treatment. Neuropathology 26:528–532CrossRefPubMed
46.
Zurück zum Zitat Hardy JA (1992) An anatomical cascade hypothesis for Alzheimer’s disease. Trends Neurosci 15:200–201CrossRefPubMed Hardy JA (1992) An anatomical cascade hypothesis for Alzheimer’s disease. Trends Neurosci 15:200–201CrossRefPubMed
47.
Zurück zum Zitat Hardy JA (2006) The amyloid hypothesis: history and alternatives. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 151–156CrossRef Hardy JA (2006) The amyloid hypothesis: history and alternatives. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 151–156CrossRef
48.
Zurück zum Zitat Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185CrossRefPubMed Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185CrossRefPubMed
49.
Zurück zum Zitat Hardy JA, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356CrossRefPubMed Hardy JA, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356CrossRefPubMed
50.
Zurück zum Zitat Hawkes CH, Doty RL (2010) The neurology of olfaction. Cambridge University Press, Cambridge, pp 153–214 Hawkes CH, Doty RL (2010) The neurology of olfaction. Cambridge University Press, Cambridge, pp 153–214
51.
Zurück zum Zitat Hyman BT, Goméz-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353–354CrossRefPubMed Hyman BT, Goméz-Isla T (1994) Alzheimer’s disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353–354CrossRefPubMed
52.
Zurück zum Zitat Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097CrossRefPubMed Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097CrossRefPubMed
53.
Zurück zum Zitat Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53–69CrossRefPubMed Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53–69CrossRefPubMed
54.
Zurück zum Zitat Jack CR, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9:119–128CrossRefPubMed Jack CR, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9:119–128CrossRefPubMed
55.
Zurück zum Zitat Klosen P, Maessen X, de Aguilar P (1993) PEG embedding for immunocytochemistry: application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455–463PubMed Klosen P, Maessen X, de Aguilar P (1993) PEG embedding for immunocytochemistry: application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455–463PubMed
56.
Zurück zum Zitat Kok E, Haikonen S, Luoto T et al (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650–657CrossRefPubMed Kok E, Haikonen S, Luoto T et al (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65:650–657CrossRefPubMed
57.
Zurück zum Zitat Kovacech B, Skrabana R, Novak M (2010) Transition of tau protein from disordered to misordered in Alzheimer’s disease. Neurodegener Dis 7:24–27CrossRefPubMed Kovacech B, Skrabana R, Novak M (2010) Transition of tau protein from disordered to misordered in Alzheimer’s disease. Neurodegener Dis 7:24–27CrossRefPubMed
58.
Zurück zum Zitat Lee VM-Y, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Ann Rev Neurosci 24:1121–1159CrossRefPubMed Lee VM-Y, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Ann Rev Neurosci 24:1121–1159CrossRefPubMed
59.
Zurück zum Zitat Li B, Chohan MO, Grundke-Iqbal I, Iqbal K (2007) Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113:501–511CrossRefPubMed Li B, Chohan MO, Grundke-Iqbal I, Iqbal K (2007) Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau. Acta Neuropathol 113:501–511CrossRefPubMed
60.
Zurück zum Zitat Li S, Shankar GM, Selkoe DJ (2010) How do soluble oligomers of amyloid beta-protein impair hippocampal synaptic plasticity? Front Cell Neurosci 4:5PubMed Li S, Shankar GM, Selkoe DJ (2010) How do soluble oligomers of amyloid beta-protein impair hippocampal synaptic plasticity? Front Cell Neurosci 4:5PubMed
61.
Zurück zum Zitat Mandelkow EM, Thiers E, Biernat J, Mandelkow E (2006) Influence of tau on neuronal traffic mechanisms. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 345–354CrossRef Mandelkow EM, Thiers E, Biernat J, Mandelkow E (2006) Influence of tau on neuronal traffic mechanisms. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 345–354CrossRef
62.
Zurück zum Zitat Mandelkow E, von Bergen M, Biernat J, Mandelkow EM (2007) Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol 17:83–90CrossRefPubMed Mandelkow E, von Bergen M, Biernat J, Mandelkow EM (2007) Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol 17:83–90CrossRefPubMed
63.
Zurück zum Zitat Mattson MP (2006) Molecular and cellular pathways towards and away from Alzheimer’s disease. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 371–378CrossRef Mattson MP (2006) Molecular and cellular pathways towards and away from Alzheimer’s disease. In: Jucker M, Beyreuther K, Haass C, Nitsch R, Christen Y (eds) Alzheimer: 100 years and beyond. Springer, Berlin, pp 371–378CrossRef
64.
Zurück zum Zitat Mattsson N, Sävman K, Osterlundh G, Blennow K, Zetterberg H (2010) Converging molecular pathways in human and neural development and degeneration. Neurosci Res 66:330–332CrossRefPubMed Mattsson N, Sävman K, Osterlundh G, Blennow K, Zetterberg H (2010) Converging molecular pathways in human and neural development and degeneration. Neurosci Res 66:330–332CrossRefPubMed
65.
Zurück zum Zitat McKee AC, Cantu RC, Nowinsky CJ, Hedley-White ET et al (2009) Chronic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68:709–735CrossRefPubMed McKee AC, Cantu RC, Nowinsky CJ, Hedley-White ET et al (2009) Chronic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68:709–735CrossRefPubMed
66.
Zurück zum Zitat Mesulam MM (1996) The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer’s disease. Prog Brain Res 109:285–297CrossRefPubMed Mesulam MM (1996) The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer’s disease. Prog Brain Res 109:285–297CrossRefPubMed
67.
Zurück zum Zitat Mesulam MM, Shaw P, Mash D, Weintraub S (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55:815–828CrossRefPubMed Mesulam MM, Shaw P, Mash D, Weintraub S (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55:815–828CrossRefPubMed
68.
Zurück zum Zitat Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188–197CrossRefPubMed Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188–197CrossRefPubMed
69.
Zurück zum Zitat Mouton PR, Pakkenberg B, Gundersen HJ, Price DL (1994) Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals. J Chem Neuroanat 7:185–190CrossRefPubMed Mouton PR, Pakkenberg B, Gundersen HJ, Price DL (1994) Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals. J Chem Neuroanat 7:185–190CrossRefPubMed
70.
Zurück zum Zitat Ohm TG, Braak H (1987) Olfactory bulb changes in Alzheimer’s disease. Acta Neuropathol 73:365–369CrossRefPubMed Ohm TG, Braak H (1987) Olfactory bulb changes in Alzheimer’s disease. Acta Neuropathol 73:365–369CrossRefPubMed
71.
Zurück zum Zitat Omalu BI, Bailes J, Hammers JL, Fitzsimmons RP (2010) Chronic traumatic encephalopathy, suicides, and parasuicides in professional American athletes: the role of the forensic pathologist. Am J Forensic Med Pathol 31:130–132CrossRefPubMed Omalu BI, Bailes J, Hammers JL, Fitzsimmons RP (2010) Chronic traumatic encephalopathy, suicides, and parasuicides in professional American athletes: the role of the forensic pathologist. Am J Forensic Med Pathol 31:130–132CrossRefPubMed
72.
Zurück zum Zitat Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol 49:53–66CrossRefPubMed Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann Neurol 49:53–66CrossRefPubMed
73.
Zurück zum Zitat Pearson J, Goldstein M, Markey K, Brandeis L (1983) Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3–32CrossRefPubMed Pearson J, Goldstein M, Markey K, Brandeis L (1983) Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3–32CrossRefPubMed
74.
Zurück zum Zitat Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Appl Neurol 69:40–52CrossRef Pikkarainen M, Martikainen P, Alafuzoff I (2010) The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Appl Neurol 69:40–52CrossRef
75.
Zurück zum Zitat Pimplikar SW (2009) Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41:1261–1268CrossRefPubMed Pimplikar SW (2009) Reassessing the amyloid cascade hypothesis of Alzheimer’s disease. Int J Biochem Cell Biol 41:1261–1268CrossRefPubMed
76.
Zurück zum Zitat Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neuritis in Parkinson’s disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98:461–464CrossRefPubMed Sandmann-Keil D, Braak H, Okochi M, Haass C, Braak E (1999) Alpha-synuclein immunoreactive Lewy bodies and Lewy neuritis in Parkinson’s disease are detectable by an advanced silver-staining technique. Acta Neuropathol 98:461–464CrossRefPubMed
77.
Zurück zum Zitat Saper CB (1987) Diffuse cortical projection systems: anatomical organization and role in cortical function. In: Plum F (ed) Handbook of physiology, vol. 5, The nervous system. Am Physiol Soc, Bethesda, pp 169–210 Saper CB (1987) Diffuse cortical projection systems: anatomical organization and role in cortical function. In: Plum F (ed) Handbook of physiology, vol. 5, The nervous system. Am Physiol Soc, Bethesda, pp 169–210
78.
Zurück zum Zitat Saper CB (1990). Cholinergic system. In: Paxinos G (ed) The human nervous system. Academic Press, New York, pp 1095–1013 Saper CB (1990). Cholinergic system. In: Paxinos G (ed) The human nervous system. Academic Press, New York, pp 1095–1013
79.
Zurück zum Zitat Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223CrossRefPubMed Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223CrossRefPubMed
80.
Zurück zum Zitat Sassin I, Schultz C, Thal DR et al (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100:259–269CrossRefPubMed Sassin I, Schultz C, Thal DR et al (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100:259–269CrossRefPubMed
81.
Zurück zum Zitat Schönheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697–711CrossRefPubMed Schönheit B, Zarski R, Ohm TG (2004) Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25:697–711CrossRefPubMed
82.
Zurück zum Zitat Selkoe DJ (2003) Aging, amyloid, and Alzheimer’s disease: a perspective in honor of Carl Cotman. Neurochem Res 28:1705–1713CrossRefPubMed Selkoe DJ (2003) Aging, amyloid, and Alzheimer’s disease: a perspective in honor of Carl Cotman. Neurochem Res 28:1705–1713CrossRefPubMed
83.
Zurück zum Zitat Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR (2009) Does Alzheimer’s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532–554CrossRefPubMed Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, Hof PR (2009) Does Alzheimer’s disease begin in the brainstem? Neuropathol Appl Neurobiol 35:532–554CrossRefPubMed
84.
Zurück zum Zitat Smith C, Graham DI, Murray LS, Nicoll JA (2003) Tau immunohistochemistry in acute brain injury. Neuropathol Appl Neurobiol 29:496–502CrossRefPubMed Smith C, Graham DI, Murray LS, Nicoll JA (2003) Tau immunohistochemistry in acute brain injury. Neuropathol Appl Neurobiol 29:496–502CrossRefPubMed
85.
Zurück zum Zitat Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051–1063CrossRefPubMed Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051–1063CrossRefPubMed
86.
Zurück zum Zitat Takeda S, Hashimoto M, Mallory M et al (1998) Abnormal distribution of the non-Aβ component of Alzheimer’s disease and amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Investig 78:1169–1177PubMed Takeda S, Hashimoto M, Mallory M et al (1998) Abnormal distribution of the non-Aβ component of Alzheimer’s disease and amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Investig 78:1169–1177PubMed
87.
Zurück zum Zitat Tanzi RE, Bertram I (2005) Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120:545–555CrossRefPubMed Tanzi RE, Bertram I (2005) Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell 120:545–555CrossRefPubMed
88.
89.
Zurück zum Zitat Teter B, Ashford JW (2002) Neuroplasticity in Alzheimer’s disease. J Neurosci Res 70:402–437CrossRefPubMed Teter B, Ashford JW (2002) Neuroplasticity in Alzheimer’s disease. J Neurosci Res 70:402–437CrossRefPubMed
90.
Zurück zum Zitat Thal DR, Rüb U, Schultz C et al (2000) Sequence of Aβ-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733–748PubMed Thal DR, Rüb U, Schultz C et al (2000) Sequence of Aβ-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733–748PubMed
91.
Zurück zum Zitat Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMed
92.
Zurück zum Zitat Tolnay M, Probst A (1999) Review: tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171–187CrossRefPubMed Tolnay M, Probst A (1999) Review: tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171–187CrossRefPubMed
93.
Zurück zum Zitat Trojanowski JQ, Lee VMY (2000) “Fatal attractions” of proteins. A comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders. Ann NY Acad Sci 924:62–67CrossRefPubMed Trojanowski JQ, Lee VMY (2000) “Fatal attractions” of proteins. A comprehensive hypothetical mechanism underlying Alzheimer’s disease and other neurodegenerative disorders. Ann NY Acad Sci 924:62–67CrossRefPubMed
94.
Zurück zum Zitat Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342–345CrossRefPubMed Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer’s disease. Curr Alzheimer Res 5:342–345CrossRefPubMed
95.
Zurück zum Zitat Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341CrossRefPubMed Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341CrossRefPubMed
96.
Zurück zum Zitat Zweig RM, Ross CA, Hedreen JC et al (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24:233–242CrossRefPubMed Zweig RM, Ross CA, Hedreen JC et al (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24:233–242CrossRefPubMed
Metadaten
Titel
The pathological process underlying Alzheimer’s disease in individuals under thirty
verfasst von
Heiko Braak
Kelly Del Tredici
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2011
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0789-4

Weitere Artikel der Ausgabe 2/2011

Acta Neuropathologica 2/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.